789 related articles for article (PubMed ID: 23135763)
21. Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.
Matsubayashi H
J Gastroenterol; 2011 Nov; 46(11):1249-59. PubMed ID: 21847571
[TBL] [Abstract][Full Text] [Related]
22. New strategies for the early detection of pancreatic cancer.
Petrone MC; Arcidiacono PG
Expert Rev Gastroenterol Hepatol; 2016; 10(2):157-9. PubMed ID: 26582179
[TBL] [Abstract][Full Text] [Related]
23. Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound.
Sud A; Wham D; Catalano M; Guda NM
Pancreas; 2014 Apr; 43(3):458-61. PubMed ID: 24622079
[TBL] [Abstract][Full Text] [Related]
24. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
[TBL] [Abstract][Full Text] [Related]
25. Development of a high risk pancreatic screening clinic using 3.0 T MRI.
Barnes CA; Krzywda E; Lahiff S; McDowell D; Christians KK; Knechtges P; Tolat P; Hohenwalter M; Dua K; Khan AH; Evans DB; Geurts J; Tsai S
Fam Cancer; 2018 Jan; 17(1):101-111. PubMed ID: 29101607
[TBL] [Abstract][Full Text] [Related]
26. Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?
Bartsch DK; Dietzel K; Bargello M; Matthaei E; Kloeppel G; Esposito I; Heverhagen JT; Gress TM; Slater EP; Langer P
Fam Cancer; 2013 Mar; 12(1):89-96. PubMed ID: 23179793
[TBL] [Abstract][Full Text] [Related]
27. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
[TBL] [Abstract][Full Text] [Related]
28. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
29. Familial Pancreatic Cancer and the Future of Directed Screening.
Welinsky S; Lucas AL
Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837
[TBL] [Abstract][Full Text] [Related]
30. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?
Torphy RJ; Schulick RD
Surg Clin North Am; 2018 Feb; 98(1):25-35. PubMed ID: 29191275
[TBL] [Abstract][Full Text] [Related]
31. Familial pancreatic carcinoma in Jews.
Lynch HT; Deters CA; Lynch JF; Brand RE
Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
[TBL] [Abstract][Full Text] [Related]
32. Familial pancreatic cancer--current knowledge.
Bartsch DK; Gress TM; Langer P
Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):445-53. PubMed ID: 22664588
[TBL] [Abstract][Full Text] [Related]
33. [Hereditary pancreatic cancer].
Habbe N; Langer P; Bartsch DK
Chirurg; 2008 Nov; 79(11):1029-37. PubMed ID: 18818893
[TBL] [Abstract][Full Text] [Related]
34. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
[TBL] [Abstract][Full Text] [Related]
35. Concordance of EUS and MRI/MRCP findings among high-risk individuals undergoing pancreatic cancer screening.
Siegel A; Friedman M; Feldman D; Krishnan K; Casey B; Pisuchpen N; Kambadakone A; Chung DC
Pancreatology; 2022 Nov; 22(7):951-958. PubMed ID: 35995658
[TBL] [Abstract][Full Text] [Related]
36. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
37. Effective screening for early diagnosis of pancreatic cancer.
Hanada K; Okazaki A; Hirano N; Izumi Y; Minami T; Ikemoto J; Kanemitsu K; Hino F
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):929-39. PubMed ID: 26651254
[TBL] [Abstract][Full Text] [Related]
38. Variation in precursor lesions of pancreatic cancer among high-risk groups.
Potjer TP; Schot I; Langer P; Heverhagen JT; Wasser MN; Slater EP; Klöppel G; Morreau HM; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bargello M; Gress TM; Vasen HF; Bartsch DK; ;
Clin Cancer Res; 2013 Jan; 19(2):442-9. PubMed ID: 23172884
[TBL] [Abstract][Full Text] [Related]
39. Surveillance of high-risk individuals for pancreatic cancer with EUS and MRI: A meta-analysis.
Kogekar N; Diaz KE; Weinberg AD; Lucas AL
Pancreatology; 2020 Dec; 20(8):1739-1746. PubMed ID: 33077384
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.
Daudé M; Muscari F; Buscail C; Carrère N; Otal P; Selves J; Buscail L; Bournet B
World J Gastroenterol; 2015 Mar; 21(9):2658-67. PubMed ID: 25759534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
